|
Y90 + Atezolizumab and Bevacizumab Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- Northwestern University1
Indications
- Liver Disease1
- Liver Cancer1
- Hepatocellular Carcinoma1
- Cancer1
Chicago, Illinois1 trial
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Northwestern University
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.